Classification of triple negative breast cancer by epithelial mesenchymal transition and the tumor immune microenvironment

Triple-negative breast cancer (TNBC) accounts for about 15–20% of all breast cancers and differs from other invasive breast cancer types because it grows and spreads rapidly, it has limited treatment options and typically worse prognosis. Since TNBC does not express estrogen or progesterone receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Font-Clos, Francesc, Zapperi, Stefano, La Porta, Caterina A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187759/
https://www.ncbi.nlm.nih.gov/pubmed/35688895
http://dx.doi.org/10.1038/s41598-022-13428-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187759/
https://www.ncbi.nlm.nih.gov/pubmed/35688895
http://dx.doi.org/10.1038/s41598-022-13428-2

Ejemplares similares